Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial
In brief
A small randomised controlled trial compared ultrasound-guided platelet-rich plasma (PRP) with autologous whole blood for chronic lateral elbow epicondylitis, with an eccentric exercise programme for everyone. The authors report that PRP eased pain more, though the difference was clear only in the early weeks, and that details such as dosing and timing still need defining.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial Authors: Christos Thanasas, George Papadimitriou, Charalambos Charalambidis, Ilias Paraskevopoulos, Athanasios Papanikolaou Link: https://www.ncbi.nlm.nih.gov/pubmed/21813443 Year of Publication: 2011
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

